These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
400 related articles for article (PubMed ID: 23913730)
1. The expression of FTO in human adipose tissue is influenced by fat depot, adiposity, and insulin sensitivity. Bravard A; Veilleux A; Disse E; Laville M; Vidal H; Tchernof A; Rieusset J Obesity (Silver Spring); 2013 Jun; 21(6):1165-73. PubMed ID: 23913730 [TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory profile of FTO gene expression in adipose tissues from morbidly obese women. Terra X; Auguet T; Porras JA; Quintero Y; Aguilar C; Luna AM; Hernández M; Sabench F; del Castillo D; Richart C Cell Physiol Biochem; 2010; 26(6):1041-50. PubMed ID: 21220935 [TBL] [Abstract][Full Text] [Related]
3. Subcutaneous and visceral adipose tissue FTO gene expression and adiposity, insulin action, glucose metabolism, and inflammatory adipokines in type 2 diabetes mellitus and in health. Samaras K; Botelho NK; Chisholm DJ; Lord RV Obes Surg; 2010 Jan; 20(1):108-13. PubMed ID: 19763711 [TBL] [Abstract][Full Text] [Related]
4. FTO mRNA expression in extremely obese and type 2 diabetic human omental and subcutaneous adipose tissues. Süsleyici-Duman B; Zengin K; Kayhan FE; Koldemir M; Dağıstanlı FK; Cağatay P; Oztürk M; Taşkın M Obes Surg; 2011 Nov; 21(11):1766-73. PubMed ID: 21598006 [TBL] [Abstract][Full Text] [Related]
5. [Expression of omentin in adipose tissues in obese and type 2 diabetic patients]. Cai RC; Wei L; DI JZ; Yu HY; Bao YQ; Jia WP Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):381-4. PubMed ID: 19567114 [TBL] [Abstract][Full Text] [Related]
6. Deleted in breast cancer 1 plays a functional role in adipocyte differentiation. Moreno-Navarrete JM; Moreno M; Vidal M; Ortega F; Serrano M; Xifra G; Ricart W; Fernández-Real JM Am J Physiol Endocrinol Metab; 2015 Apr; 308(7):E554-61. PubMed ID: 25648830 [TBL] [Abstract][Full Text] [Related]
7. Regulation of adiponectin secretion in human subcutaneous and omental adipose tissue: effects of pioglitazone and endothelin-1: a pilot study. Mahadik SR; Lele RD; Mehtalia SD; Deo SS; Parikh V J Assoc Physicians India; 2013 Apr; 61(4):244-8. PubMed ID: 24482963 [TBL] [Abstract][Full Text] [Related]
8. Inverse relationship between obesity and FTO gene expression in visceral adipose tissue in humans. Klöting N; Schleinitz D; Ruschke K; Berndt J; Fasshauer M; Tönjes A; Schön MR; Kovacs P; Stumvoll M; Blüher M Diabetologia; 2008 Apr; 51(4):641-7. PubMed ID: 18251005 [TBL] [Abstract][Full Text] [Related]
9. The FTO obesity gene. Genotyping and gene expression analysis in morbidly obese patients. Zabena C; González-Sánchez JL; Martínez-Larrad MT; Torres-García A; Alvarez-Fernández-Represa J; Corbatón-Anchuelo A; Pérez-Barba M; Serrano-Ríos M Obes Surg; 2009 Jan; 19(1):87-95. PubMed ID: 18855084 [TBL] [Abstract][Full Text] [Related]
10. Glucose uptake and insulin action in human adipose tissue--influence of BMI, anatomical depot and body fat distribution. Stolic M; Russell A; Hutley L; Fielding G; Hay J; MacDonald G; Whitehead J; Prins J Int J Obes Relat Metab Disord; 2002 Jan; 26(1):17-23. PubMed ID: 11791142 [TBL] [Abstract][Full Text] [Related]
11. Glucose transporter 4 and insulin receptor substrate-1 messenger RNA expression in omental and subcutaneous adipose tissue in women. Veilleux A; Blouin K; Rhéaume C; Daris M; Marette A; Tchernof A Metabolism; 2009 May; 58(5):624-31. PubMed ID: 19375584 [TBL] [Abstract][Full Text] [Related]
12. CDKN2C expression in adipose tissue is reduced in type II diabetes and central obesity: impact on adipocyte differentiation and lipid storage? Pereira MJ; Vranic M; Kamble PG; Jernow H; Kristófi R; Holbikova E; Skrtic S; Kullberg J; Svensson MK; Hetty S; Eriksson JW Transl Res; 2022 Apr; 242():105-121. PubMed ID: 34896253 [TBL] [Abstract][Full Text] [Related]
13. Metabolomics uncovers the role of adipose tissue PDXK in adipogenesis and systemic insulin sensitivity. Moreno-Navarrete JM; Jove M; Ortega F; Xifra G; Ricart W; Obis È; Pamplona R; Portero-Otin M; Fernández-Real JM Diabetologia; 2016 Apr; 59(4):822-32. PubMed ID: 26831303 [TBL] [Abstract][Full Text] [Related]
15. Gene expression of FTO in human subcutaneous adipose tissue, peripheral blood mononuclear cells and adipocyte cell line. Lappalainen T; Kolehmainen M; Schwab U; Pulkkinen L; de Mello VD; Vaittinen M; Laaksonen DE; Poutanen K; Uusitupa M; Gylling H J Nutrigenet Nutrigenomics; 2010; 3(1):37-45. PubMed ID: 20948226 [TBL] [Abstract][Full Text] [Related]
16. Depot-specific regulation of perilipin by rosiglitazone in a diabetic animal model. Kim HJ; Jung TW; Kang ES; Kim DJ; Ahn CW; Lee KW; Lee HC; Cha BS Metabolism; 2007 May; 56(5):676-85. PubMed ID: 17445544 [TBL] [Abstract][Full Text] [Related]
17. PPARgamma2 protects against obesity by means of a mechanism that mediates insulin resistance. Macias-Gonzalez M; Moreno-Santos I; García-Almeida JM; Tinahones FJ; Garcia-Fuentes E Eur J Clin Invest; 2009 Nov; 39(11):972-9. PubMed ID: 19645740 [TBL] [Abstract][Full Text] [Related]
18. The Demethylase Activity of FTO (Fat Mass and Obesity Associated Protein) Is Required for Preadipocyte Differentiation. Zhang M; Zhang Y; Ma J; Guo F; Cao Q; Zhang Y; Zhou B; Chai J; Zhao W; Zhao R PLoS One; 2015; 10(7):e0133788. PubMed ID: 26218273 [TBL] [Abstract][Full Text] [Related]
19. Expression pattern of tumour necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non-insulin-dependent diabetes mellitus. Hube F; Birgel M; Lee YM; Hauner H Eur J Clin Invest; 1999 Aug; 29(8):672-8. PubMed ID: 10457150 [TBL] [Abstract][Full Text] [Related]
20. Paired subcutaneous and visceral adipose tissue aquaporin-7 expression in human obesity and type 2 diabetes: differences and similarities between depots. Miranda M; Escoté X; Ceperuelo-Mallafré V; Alcaide MJ; Simón I; Vilarrasa N; Wabitsch M; Vendrell J J Clin Endocrinol Metab; 2010 Jul; 95(7):3470-9. PubMed ID: 20463097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]